This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Nasal Polyposis
  • /
  • Targetable pathogenic mechanisms in nasal polyposi...
Journal

Targetable pathogenic mechanisms in nasal polyposis

Read time: 1 mins
Published:2nd Mar 2021
Author: Schneider AL, Schleimer RP, Tan BK.
Availability: Free full text
Ref.:Int Forum Allergy Rhinol. 2021 Mar 3.
DOI:10.1002/alr.22787
Targetable pathogenic mechanisms in nasal polyposis


Chronic rhinosinusitis with nasal polyps (CRSwNP) represents a challenging disease entity with significant rates of recurrence following appropriate medical and surgical therapy. Recent approval of targeted biologics in CRSwNP compels deeper understanding of underlying disease pathophysiology. Both of the approved biologics for CRSwNP modulate the type 2 inflammatory pathway, and the majority of drugs in the clinical trials pathway are similarly targeted. However, there remain multiple other pathogenic mechanisms relevant to CRSwNP for which targeted therapeutics already exist in other inflammatory diseases that have not been studied directly. In this article we summarize pathogenic mechanisms of interest in CRSwNP and discuss the results of ongoing clinical studies of targeted therapeutics in CRSwNP and other related human inflammatory diseases.


Read abstract on library site  Access full article